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Abstract
Background: Overexpression of Pim-1 in stem/progenitor cells stimulated cell cycling and enhanced cardiac
regeneration in vivo. We proposed that hypoxic preconditioning could increase survival of bone marrow
mesenchymal stem cells (MSCs) via upregulation of Pim-1 and aimed to determine the microRNAs that modulate
the expression of Pim-1.
Methods and results: MSCs were subjected to hypoxia exposure. The expression of Pim-1 in MSCs was enhanced in a
time-dependent manner, detected by quantitative PCR and western blot. miR-206 is predicted as one of the potential
microRNAs that target Pim-1. The expression of miR-206 was decreased in hypoxic MSCs and reversely correlated with
Pim-1 expression. Luciferase activity assay further confirmed Pim-1 as a putative target of miR-206. In addition, gain and
loss-of-function studies with miR-206 mimics and inhibitors showed that inhibition of miR-206 in hypoxic MSCs promoted
the migration ability of the cells, prevented cell apoptosis, and protected membrane potential of mitochondria, while the
benefits were all blocked by Pim-1 inhibitor. In an acute model of myocardial infarction, transplanted hypoxic MSCs
showed a significantly improved survival as compared with hypoxic MSCs overexpressing miR-206.
Conclusions: Hypoxic preconditioning could increase short-term survival of bone marrow MSCs via upregulation of Pim-
1, and miR-206 was one of the critical regulators in this process.
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Background
Pim-1, a proto-oncogenic serine–threonine kinase, was
originally discovered as the proviral integration site for
Moloney murine leukemia virus [1]. Pim-1 plays a role in
the proliferation and survival of hematopoietic cells [2].
However, the role of Pim-1 in cardiac development has
been overlooked for a long time. In 2007, Dr Mark A
Sussman reported that Pim-1 could regulate cardiomyo-
cyte survival downstream of Akt using Pim-1-deficient
mice [3]. Also, overexpression of Pim-1 inhibited cardio-
myocyte apoptosis and protected mice from infarction
injury, which revealed the potential cardioprotective role
of Pim-1. Successively, Sussman’s group showed that over-
expression of Pim-1 in cardiac progenitor cells enhanced
cardiac regeneration [4] and stimulated cell cycling [5].
Rejuvenation of stem cells by Pim-1 overexpression thus
endued the cells with increased proliferative and regene-
rative potentials [6–8]. However, genetic modification of
stem cells is not the first promising option in their
utilization for tissue regeneration. In 2014, Hu et al. [9] re-
ported that hypoxic preconditioning increases survival of
cardiac progenitor cells via upregulation of Pim-1, discov-
ering a method for nongenetic modification of Pim-1 in
stem cells. In our study, we proposed that hypoxic precon-
ditioning could increase survival of bone marrow mesen-
chymal stem cells (MSCs) via upregulation of Pim-1 and
aimed to determine some microRNAs (miRNAs) that
modulate the expression of Pim-1.
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We demonstrated that hypoxia preconditioning en-
hanced the expression of Pim-1 kinase in MSCs in a time-
dependent manner, as detected by quantitative PCR
(qPCR) and western blot. We further predicted that
microRNA-206 (miR-206) is one of the potential miRNAs
that targets Pim-1 through TargetScan, microRNA, and
miRDB software. In addition, miR-206 is a potential regu-
lator of proliferation, apoptosis, and differentiation of
pulmonary artery smooth muscle cells [10].
We confirmed that the expression of miR-206 was de-
creased in hypoxic MSCs. Next, qPCR analysis revealed
that miR-206 reversely regulated the expression of
Pim-1. Luciferase activity assay further confirmed Pim-1
as a putative target of miR-206. In addition, gain and loss-
of-function studies with miR-206 mimics and inhibitors
showed that inhibition of miR-206 in HP-MSCs promoted
the migration ability of the cells, prevented cell apoptosis,
and protected membrane potential of mitochondria, while
the benefits were all blocked by Pim-1 inhibitor. In an
acute model of myocardial infarction, transplanted HP-
MSCs showed significantly improved survival as com-
pared with hypoxic MSCs overexpressing miR-206. In
conclusion, hypoxic preconditioning could increase short-
term survival of bone marrow MSCs via upregulation of




All animal procedures were approved by the Ethic
Committee of Soochow University, Suzhou, China and
were carried out in accordance with the Guidelines for
the Care and Use of Research Animals established by
Soochow University. Rats were housed at the Animal
Facility of Soochow University on a 12-h light/dark cycle
with free access to water and standard mouse food.
Isolation and culture of bone marrow MSCs
Bone marrow MSCs were isolated from 4-week-old
Sprague–Dawley rats. Briefly, the bone marrow was
flushed from the femora of rats with low-glucose DMEM
(Gibco, Gaithersburg, MD, USA), 10 % FBS (Gibco), and
1 % penicillin–streptomycin (HyClone, Logan, Utah,
USA). Cells were collected and seeded onto a 10-cm
diameter plate, and incubated in 5 % CO2 at 37 °C. After
24 h of incubation, the medium was changed first and re-
placed every 3 days thereafter. When at 80–90 % conflu-
ence, MSCs were dissociated with 0.25 % trypsin (Sangon
biotech, Shanghai, China) and expanded at a 1:2 dilution.
MSCs at passage 4 were used in all experiments.
Hypoxia preconditioning of MSCs in vitro
For hypoxic culture, cells were cultured in a tri-gas incuba-
tor (Thermo Fisher Scientific, Marietta, OH, USA cell,
Germany) composed of 94 % N2, 5 % CO2, and 1 % O2. To
determine the optimal time length for hypoxic treatment,
cells were cultured for 6, 12, and 24 h in hypoxia. MSCs
were thus divided into four groups: normoxia, hypoxia for
6 h, hypoxia for 12 h, and hypoxia for 24 h. During the hyp-
oxic preconditioning, MSCs were incubated with Querceta-
getin (Calbiochem, San Diego, CA, USA), a specific Pim-1
activity inhibitor, at 10 μmol/l.
Western blot
MSCs were lysed with lysis buffer including 1 % phenyl-
methane sulfonylfluoride (PMSF) and 1 % phosphatase in-
hibitors and the protein was extracted. The protein
concentration was determined using a BCA Protein Assay
Kit (Beyotime Biotechnology, Shanghai, China). The pro-
tein sample extracted from MSCs was separated by 10 %
SDS-PAGE (for Pim-1 and β-actin) and transferred to a
0.45 mm nitrocellulose membrane (Millipore, Billerica,
MA, USA) using a Trans-Blot SD Semi-Dry Electrophoretic
Transfer Cell (Bio-Rad, Hercules, California, USA). Milk
5 % (w/v) in 0.1 % Tween 20/PBS was used to block the
membranes for 1 h. The membranes were then incubated
with rabbit polyclonal antibody against Pim-1 (1:100; Santa
Cruz, Dallas, Texas, USA) and β-actin (1:1000; Beyotime
Biotechnology) overnight and blotted with a HRP-linked
secondary antibody (1:1000; Beyotime Biotechnology) for
2 h. Afterwards, the protein band could be visualized via
enhanced chemiluminescence and analyzed by the Scion
Image Software (Scion, Frederich, MD, USA).
Target gene prediction
Three target prediction algorithms—TargetScan 6.2
(http://www.targetscan.org/), mirWALK (http://zmf.umm.
uni-heidelberg.de/apps/zmf/mirwalk2/), and mircroRNA.
org (http://www.microrna.org/microrna/)—were used to
predict the potential target relationship between miR-206
and Pim-1.
microRNA expression level in MSCs
Total RNA was extracted from rat MSCs using the Pure-
Link™ RNA Mini Kit (Ambion, Foster City, CA, USA) and
quantified using an ND2000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). The extracted RNA
was subjected to RT-PCR using the Hairpin-it™ miRNAs
RT-PCR Quantitation Kit (GenePharma, Shanghai, China).
miRNA expression levels were measured using Step One-
Plus Real-Time PCR System (Applied Biosystems, Foster
City, CA, USA), according to the manufacturer’s instruc-
tions. miRNA expression was normalized to U6 snRNA.
Dual-luciferase reporter assays
Using standard procedures, wild-type (WT) or mutant
3′-untranslated regions (UTRs) of Pim-1 were subcloned
into the pmiR-RB-REPORT™ vector (Ribobio, Guangzhou,
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China) downstream of the luciferase gene. Pim-1-3′-UTR-
WT or Pim-1-3′-UTR-Mut vectors were cotransfected
with miR-206 mimics or negative control into MSCs,
using Lipofectamine 2000 for 48 h. Firefly luciferase activ-
ity was measured at 48 h post transfection, using a Dual-
Luciferase Reporter Assay System (Promega Corporation,
Fitchburg, WI, USA), according to the manufacturer’s in-
structions. Each reporter plasmid was transfected at least
three times, and each sample was assayed in triplicate.
Transfection and groups in vitro
The miR-206 oligonucleotides including mimics, inhibitors,
and negative control were purchased from GenePharma
Co., Ltd (Shanghai, China). We dissolved the oligonu-
cleotides with diethylpyrocarbonate (DEPC)-treated water
to 50 nM. Cell transfection was performed with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), ac-
cording to the manufacturer’s protocols. The efficiency of
transfection was confirmed using RT-qPCR. Cells were
then subjected to hypoxic treatment as already described.
To provide a positive control on the blocking of Pim-1
activity, Quercetagetin (Calbiochem) was also added at
10 μmol/l when cells were under hypoxic exposure. The
experimental groups are thus illustrated as follows: MSCs,
HP-MSCs, HP-MSCsmiR-206, HP-MSCsanti-miR-206, and
HP-MSCsanti-miR-206 + Pim-1 inhibitor (see Table 1).
Transwell migration assay
Cell migration assays were performed using transwell
filters with 8-μm pores (Fisher Scientific, Pittsburgh, PA,
USA). Briefly, cells (5 × 104 cells/200 μl) suspended in
serum-free DMEM were plated into the upper compart-
ment of a Transwell chamber in triplicate. Lower cham-
bers were filled with 500 μl of DMEM containing 10 %
FBS. After 4 h, cells were fixed in 4 % methanal for
20 min, stained with DAPI (Invitrogen) and counted
under a fluorescent microscope (Olympus, Tokyo, Japan).
Apoptosis assay
An Annexin V-fluorescein isothiocyanate (FITC) apop-
tosis detection kit (BD Pharmingen, San Diego, CA,
USA) was used to perform the apoptosis assay. Briefly,
1 × 106 cells were collected by trypsinization and
resuspended in binding buffer containing Annexin
V-FITC and propidium iodide. After incubation in the
dark for 15 min, MSCs were analyzed using a BD FACS
Aria flow cytometer.
Measurement of the mitochondrial membrane potential
The mitochondrial membrane potential (Δψm) was
measured using the lipophilic cationic probe JC-1 dye
(Beyotime Biotechnology), according to the manufac-
turer’s instructions. Briefly, MSCs were stained with JC-1
(5 mol/l) at 37 °C for 20 min in the dark and rinsed three
times with ice-cold working solution. The fluorescence
was then monitored by the inversion fluorescence micro-
scope (Olympus). The red fluorescence is caused by a po-
tentially dependent aggregation in the mitochondria,
reflecting Δψm. Green emission of the dye represents the
monomeric form of JC-1. Mitochondrial depolarization is
indicated by a decrease in the red/green fluorescence
intensity ratio.
Acute myocardial infarction model of rat hearts and cell
transplantation
Acute myocardial infarction (AMI) was made according to
the method described previously [11]. Thirty female young
(6–8 weeks) Sprague–Dawley rats (200–250 g) were stud-
ied. They were anesthetized once with by Avertin™
(300 mg/kg; Sigma, St. Louis, MO, USA) intraperitoneally.
After a left lateral thoracotomy, the proximal portion of
the left anterior descending artery was ligated with a 6–0
Prolene suture between the pulmonary artery outflow tract
and the left atrium. Then, 1 million MSCs from male rats
prepared in 70 μl suspension were transplanted by myo-
cardial injection at multiple sites (3–4 sites/heart) in the
free wall of the left ventricle during the acute phase of
AMI. After injection, we closed the chests of the animals
and the animals were allowed to recover. Four days later,
the animals were euthanized for collection of the heart tis-
sue samples for molecular studies.
Detection of cell survival in vivo
Cell survival was determined by detection of Sry gene
using qPCR in the myocardial tissue samples. Tissue
samples were snap-frozen in liquid nitrogen and
Table 1 Groups used for the in-vitro and in-vivo experiments
Groupa Step 1 Time (h) Step 2 Time (h)
MSCs Untreated
HP-MSCs Untreated Hypoxia exposure 12
HP-MSCsmiR-206 Transfected with miR-206 mimics 48 Hypoxia exposure 12
HP-MSCsanti-miR-206 Transfected with miR-206 inhibitor 48 Hypoxia exposure 12
HP-MSCsanti-miR-206 + Pim-1 inhibitor Transfected with miR-206 inhibitor 48 Hypoxia with Pim-1 inhibitor treatment 12
aMSCs subjected to different combinations of treatment
Step 1 first step of treatment, time length of treatment, Step 2 second step of treatment, MSC mesenchymal stem cell, HP-MSC mesenchymal stem cell subjected to
hypoxic preconditioning, miR-206 microRNA-206
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powdered. DNA purification was performed using the
Genomic DNA Isolation kit (Qiagen, Germantown, MD,
USA), and the concentration of the purified DNA was de-
termined by spectrophotometry. The primer sequences
for sry gene and β-actin were as follows: sry gene, forward
5′-GAGGCACAAGTTGGCTCAACA-3′ and reverse 5′-
CTCCTGCAAAAAGGGCCTTT-3′; β-actin, forward 5′-
CCACCATGTACCCAGGCATT-3′ and reverse 5′-
ACTCCTGCTTGCTGATCCAC-3′.
Statistical analysis
All data are shown as the mean ± standard error (SE).
Differences between two mean values were evaluated by
an unpaired Student two-tailed t test, and between three
or more groups were analyzed using one-way analysis of
variance by GraphPad Prism software (GraphPad Software
Inc., San Diego, CA, USA). P < 0.05 was considered
significant.
Results
Pim-1 expression was significantly increased in HP-MSCs
We first performed qPCR to detect the effect of hypoxic
preconditioning on the expression of Pim-1 in MSCs. A
time-course study was conducted at 0, 6, 12, and 24 h to
quantify the Pim-1 expression in MSCs under hypoxic
conditions (Fig. 1a). We observed a significant change of
Pim-1 expression under low-oxygen conditions in a
time-dependent manner. Although mildly decreased at
Fig. 1 Hypoxia preconditioning changes the expression of Pim-1 time-dependently. a Expression of Pim-1 in MSCs at 0, 6, 12, and 24 h of hypoxia
with or without Pim-1 inhibitor detected by qPCR (n = 4). **P < 0.01 vs 0 h and 6 h; ##P < 0.01 vs 0 h and 6 h. b Western blot analysis of Pim-1 in
MSCs with varied pretreatment. c Statistical analysis of Pim-1 intensity (n = 6). &&&P < 0.001 vs 0 h; ***P < 0.01 vs 0 h and 6 h; ##P < 0.01 vs 0 h
and 12 h
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6 h, the level of Pim-1 expression in hypoxic MSCs was
increased to about twofold at 12 h (P < 0.01 vs 0 h and
6 h), starting to decrease afterwards. It is worthy of note
that the expression of Pim-1 was slightly inhibited by
Quercetagetin, a specific inhibitor of Pim-1 activity
(Fig. 1a). Furthermore, western blot analysis confirmed
the tendency of Pim-1 expression (Fig. 1b, c). In contrast
with its mRNA expression, the protein expression of
Pim-1 significantly increased at 6 h under hypoxic con-
ditions, suggesting a posttranscriptional regulation of the
induction of Pim-1.
Hypoxia pretreatment suppressed miR-206 expression
and Pim-1 is a putative target of miR-206
miRNAs play a critical role in the posttranscriptional
regulation of gene expression, and thus we could deter-
mine the miRNAs modulating Pim-1. Three databases
(TargetScan, microRNA, and miRDB) were used to
predict the putative miRNAs that target Pim-1, and
miR-206 was predicted as one of the potential miRNAs
binding on the 3′-UTR of the Pim-1 gene (Fig. 2a). To
further confirm the targeting relationship between
miR-206 and Pim-1, we first analyzed miR-206 expression
using qPCR in HP-MSCs and found it was decreased to
50 ± 13 % under hypoxia vs normoxia (Fig. 2b). Further-
more, we constructed the luciferase reporter vector
(Fig. 2c) to perform the luciferase reporter assay. As shown
in Fig. 2d, miR-206 significantly decreased the relative
luciferase reporter activity of the wild-type Pim-1 3′-UTR,
whereas that of the mutant Pim-1 3′-UTR did not change
significantly, which suggests that miR-206 could directly
bind to the 3′-UTR of Pim-1. We then transfected MSCs
with miR-206 mimics or miR-206 inhibitors, and over
90 % of the cells were successfully transfected. The expres-
sion of miR-206 was significantly upregulated or downreg-
ulated after transfection with mimics and inhibitors,
respectively (Fig. 2e). qPCR showed that the inhibition of
miR-206 in MSCs was concurrent with the increased
expression of Pim-1 and vice versa (Fig. 2f). These results
provided clear evidence that hypoxia pretreatment
Fig. 2 Pim-1 is a putative target of miR-206 in MSCs. a Binding motif (2136–2142) of miR-206 on Pim-1 3′-UTR (2041–2759). b Percentages of miR-206
expression in MSCs under hypoxia vs normoxia (n= 3). *P< 0.05 vs normoxia. c Construction of luciferase construct. d Relative Rluc/Luc ratio (n= 3).
*P< 0.05 vs Pim-1-WT +NC. e Expression of miR-206 in MSCs after transfection of mimics and inhibitors (n= 6). *P< 0.05 vs non-trans, NC, and inhibitor;
#P< 0.05 vs non-trans and NC. f Expression of Pim-1 in MSCs after transfection of miR-206 mimics and inhibitors (n= 6). *P< 0.05 vs non-trans; ###P< 0.001
vs non-trans, NC negative control and mimics. miR-206 microRNA-206, MSC mesenchymal stem cell, UTR untranslated region, WT wild type
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suppressed the expression of miR-206 and Pim-1 is a puta-
tive target of miR-206.
Abrogation of miR-206 in HP-MSCs promotes the
migration ability of the cells
The transwell assay was conducted to examine the
migration abilities of MSCs under different conditions.
MSCs without any pretreatment were used as a baseline
control for all other experimental groups. As shown in
Fig. 3a, the migration ability of HP-MSCs had a sig-
nificant increase (P < 0.01 vs MSCs), but was inhibited
when overexpressing miR-206 in HP-MSCs (P < 0.001 vs
HP-MSCs). Besides, HP-MSCs with the inhibition of
miR-206 had much more migrated cells, but when the
cells were treated with Quercetagetin at the same time,
migrated cells were reduced by about 70 % (P < 0.001 vs
HP-MSCsanti-miR-206) (Fig. 3b). This suggests that hyp-
oxic preconditioning could promote the migration ability
of MSCs by inhibiting miR-206 expression, and Pim-1 is
a downstream target of miR-206.
Cytoprotective effects of Pim-1/miR-206 in HP-MSCs
To further study the role of miR-206 and Pim-1 in cyto-
protection of HP-MSCs, we examined the apoptosis of
MSCs in different groups by flow cytometry analysis
(Fig. 4a). Hypoxic pretreatment slightly delayed the early
apoptosis of the cells (P > 0.05 vs MSCs). However,
HP-MSCs overexpressing miR-206 showed a higher
apoptosis rate (P < 0.001 vs HP-MSCs) (Fig. 4b). In
addition, Pim-1 inhibition in HP-MSCs after anti-miR-206
transfection significantly accelerated the early apoptosis of
the cells (P < 0.05 vs HP-MSCsanti-miR-206), which further
confirmed the importance of miR-206 and Pim-1 in cyto-
protection of HP-MSCs and the biological relationship be-
tween them.
Inhibition of miR-206 in HP-MSCs protects the membrane
potential of mitochondria
The protective effect of Pim-1 in apoptosis via the
mitochondrial pathway has been widely studied [12].
Therefore, we performed JC-1 staining to examine the
protective effects of miR-206 and Pim-1 on mitochondrial
integrity. The red fluorescence of JC-1 is caused by a po-
tentially dependent aggregation in the mitochondria,
reflecting Δψm. Green emission of the dye represents the
monomeric form of JC-1. Mitochondrial depolarization is
indicated by a decrease in the red/green fluorescence
intensity ratio. As shown in Fig. 5a and 5b, hypoxia
exposure of MSCs significantly decreased mitochondria
depolarization compared with untreated MSCs (P < 0.05 vs
MSCs). However, the red/green ratio of JC-1 was remark-
ably decreased when HP-MSCs were transfected with miR-
Fig. 3 Hypoxia exposure of MSCs promotes the migration ability of the cells by modulation of miR-206/Pim-1. a Representative images of migrated
cells stained with DAPI. Bar, 200 μm. b Numbers of migrated cells per high-power field (HPF) were statistically analyzed (n = 4). **P < 0.01 vs MSCs;
###P < 0.001 vs HP-MSCs; &&&P < 0.001 vs HP-MSCsanti-miR-206. miR-206 microRNA-206, MSC mesenchymal stem cell, HP-MSC MSC subjected to
hypoxic preconditioning
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206 mimics (P < 0.01 vs HP-MSCs). In addition, Pim-1
inhibition in HP-MSCs after anti-miR-206 transfection
decreased the red/green ratio of JC-1 from 20 ± 7 % (HP-
MSCsanti-miR-206) to 3 ± 0.6 % (HP-MSCsanti-miR-206 + inhibitor)
(P < 0.001).
HP-MSCs with lower miR-206 showed improved survival
in the infarcted heart
MSCs from male donors were transplanted to female
rats subjected to myocardial infarction. The survival of
transplanted cells was evaluated by detection of Sry gene
in the ischemic hearts as described previously [13].
Hearts were collected 4 days after cell transplantation,
and cell survival was examined (Fig. 6a). In vivo, MSCs
survived more by hypoxic preconditioning (P < 0.05 vs
MSCs), which was prevented by overexpression of miR-206
(P < 0.01 vs HP-MSCs) (Fig. 6b). As it was observed in
vitro, inhibition of miR-206 in HP-MSCs showed improved
survival, which was prevented by Pim-1 inhibitor (P < 0.001
vs HP-MSCsanti-miR-206).
Discussion
The important findings of our study include the follow-
ing: Pim-1 kinase is upregulated in MSCs under hypoxic
conditions; miR-206 plays a mechanistic role in the
migration and survival of MSCs via its putative target
Pim-1; the prosurvival effect of miR-206/Pim-1 main-
tains the mitochondria membrane potential during hyp-
oxic treatment of MSCs; and abrogation of miR-206 in
hypoxic MSCs enhanced survival of the cells in the is-
chemic myocardium.
The role of Pim-1, a proto-oncogenic serine–threonine
kinase, in cardiac development has been overlooked for
a long time. Dr Sussman first discovered that Pim-1,
downstream of Akt, regulates cardiomyocyte survival
[3]. Regenerative therapies utilizing stem/progenitors
cells engineered with Pim-1 enhanced regenerative
potential of the cells [4, 8, 14], thus making Pim-1 an
important player in the treatment of severe heart failure.
Very recently, it was reported that hypoxic precondition-
ing increases survival of cardiac progenitor cells via
Fig. 4 Anti-apoptosis effect of miR-206/Pim-1 in HP-MSCs. a Flow cytometry analysis of apoptotic cells in different groups. b Percentages of early
apoptotic cells were statistically analyzed (n = 3). ###P < 0.001 vs HP-MSCs, &P < 0.05 vs HP-MSCsanti-miR-206. miR-206 microRNA-206, MSC mesenchymal
stem cell, HP-MSC MSC subjected to hypoxic preconditioning
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upregulation of Pim-1, discovering a method for nonge-
netic modification of Pim-1 in stem cells. Another report
[15] also claimed that Pim-1 could promote MSC prolifer-
ation and prevent MSC apoptosis. Thus we raised a pro-
posal that hypoxic preconditioning could increase survival
of MSCs via upregulation of Pim-1. Not surprisingly, we
demonstrated that Pim-1 was gradually increased, reach-
ing a peak at 12 h of hypoxia. Next, we aimed to deter-
mine the miRNAs that modulate the expression of Pim-1
in MSCs under hypoxic conditions. Through the three
Fig. 5 Inhibition of miR-206 in HP-MSCs protects membrane potential of mitochondria. a Representative images of mitochondria membrane
potential stained by JC-1. Cells treated with CCCP-1 served as a control. Bar, 200 μm. b Ratios of red/green cells were calculated and analyzed
(n = 4). *P < 0.05 vs MSCs; ###P < 0.01 vs HP-MSCs; &&P < 0.001 vs HP-MSCsanti-miR-206. miR-206 microRNA-206, MSC mesenchymal stem cell, HP-MSC
MSC subjected to hypoxic preconditioning
Fig. 6 HP-MSCs with lower miR-206 showed improved survival in the infarcted heart. a Electrophoresis analysis of sry gene in the infarcted hearts
4 days post transplantation. b Ratios of Sry/β-actin were calculated and analyzed (n = 4). *P < 0.05 vs MSCs; ##P < 0.01 vs HP-MSCs; &&&P < 0.001 vs
HP-MSCsanti-miR-206. HP hypoxic preconditioning, miR-206 microRNA-206
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target gene prediction software packages, we predicted
that miR-206, miR-328, miR-327, miR-532-3p, and miR-
760-3p had putative binding sites on the 3′-UTR region of
Pim-1. Through literature searching, we screened out
miR-206 and miR-328 since they were reported to be
downregulated in hypoxic situations [16, 17]. miR-206
was further confirmed to be downregulated in hypoxic
MSCs, while miR-328 was not changed (data not shown).
Next, the targeting relationship of miR-206 and Pim-1
was validated by qPCR and luciferase reporter activity.
Although little is known about miR-206 for its func-
tion during the preconditioning of stem cells, miR-206
has been mostly studied for its association with the
pathogenesis of human cancers. A number of studies
have shown that miR-206 is frequently downregulated in
many human malignancies, including colorectal cancer
[18], cervical cancer [19], lung cancer [20], gastric cancer
[21], and breast cancer [22], and is associated with a
malignant phenotype. These studies have validated that
upregulation of miR-206 inhibited cancer cell prolifera-
tion and migration, blocked the cell cycle, and activated
apoptosis. In our study, we observed that during the
hypoxic preconditioning of MSCs, the inhibition of miR-
206 had anti-apoptotic and migration-promoting effects
on the MSCs, which were blocked either by overexpres-
sion of miR-206 or by abrogation of Pim-1 activity using
the specific inhibitor, consistent with the observations in
cancer research. In HeLa and C2C12 cells, miR-206 tar-
gets NOTCH3 expression to induce cell-cycle arrest and
the inhibition of tumor cell migration [23]. It was also
shown that through the c-Met pathway, miR-206 effect-
ively inhibited gastric cancer progression [21]. In this
study we provide the first evidence that hypoxic precon-
ditioning regulated the expression of miR-206, which
plays an essential role in mediating migration and apop-
tosis by targeting Pim-1 kinase in MSCs.
A loss of mitochondrial membrane potential is the ini-
tial manifestation of mitochondrial damage. In the apop-
tosis pathway, mitochondrial membrane potential was
impaired first, and then apoptosis cascade starts [24, 25].
In this study, the protective effect of Pim-1/miR-206 in
HP-MSCs maintains the membrane potential of mito-
chondria, slowing down the progression of apoptosis. In
addition, hypoxic treatment significantly enhanced sur-
vival of MSCs after transplantation in ischemic hearts,
while the pretreatment of MSCs with miR-206 and
Pim-1 inhibitor significantly abolished the cytoprotec-
tive effects of preconditioning.
Conclusions
We demonstrate that miR-206 is modulated by hypoxic
preconditioning of MSCs through targeting Pim-1 kin-
ase, elucidating a new aspect of prosurvival signaling in
hypoxia. Moreover, the protective effects of miR-206/
Pim-1 in HP-MSCs supported their short-term survival
under ischemic stress after transplantation. miR-206/
Pim-1 may serve as a molecular therapeutic strategy in
stem cell translational research.
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